WELLESLEY, Mass., June 8 /PRNewswire-FirstCall/ -- Coley Pharmaceutical Group, Inc. , today announced that its Annual Meeting of Stockholders will be held on Thursday, June 14, 2007 at 8:30 a.m. Eastern Time at the company's corporate headquarters located at 93 Worcester Street, Wellesley, MA.
Interested parties may access a webcast of the Annual Meeting by visiting the Coley Pharmaceutical Group website at http://www.coleypharma.com. Investors may participate via conference call by dialing either +1-866-543-6407 in the U.S., +1-617-213-8898 outside the U.S., and typing in the passcode 34478299. A replay of the webcast will be archived on the "Investor Events" page in the Investor Center section of the Coley website until July 14, 2006.
The webcast is also being distributed through the Thomson StreetEvents Network to both institutional and individual investors. Individual investors can listen to the meeting at www.earnings.com and institutional investors can access the webcast via www.streetevents.com.
About Coley Pharmaceutical Group
Coley Pharmaceutical Group, Inc. is an international biopharmaceutical company, headquartered in Wellesley, Massachusetts, USA, that discovers and develops TLR Therapeutics(TM), a new class of investigational drug candidates that direct the human immune system to fight cancers, asthma and allergic diseases and to enhance the effectiveness of vaccines. Coley has established a pipeline of TLR Therapeutic product candidates currently advancing through clinical development with partners and has additional product candidates in preclinical development. Coley has product development, research and license agreements with Pfizer, sanofi-aventis, GlaxoSmithKline, Novartis Vaccines, Merck and the United States government. For further information on Coley Pharmaceutical Group please visit www.coleypharma.com.
Coley Pharmaceutical Group, Inc.CONTACT: Susan Hager, Senior Director, Investor Relations and CorporateCommunications of Coley Pharmaceutical Group, +1-781-431-9079,shager@coleypharma.com; or Karen L. Bergman, +1-650-575-1509,kbergman@bccpartners.com, or Michelle Corral, +1-415-794-8662,mcorral@bccpartners.com, of BCC Partners (US)
Web site: http://www.coleypharma.com//
